3 way-too-early extensions Yankees should consider before 2024 season
We weigh the pros and cons and deliver a verdict. You want to be like the Braves, though, right?
Everywhere you look, baseball's shrewdest teams are getting lightyears ahead of potential pitfalls down the line by extending their hottest rookies on lengthy (but still bargain) contracts.
Corbin Carroll became a D-Back for life (or, at least, the portion of his life that lasts through 2031) prior to Opening Day of 2023. The team bet on a Rookie of the Year campaign, and they've been proven correct, risking only $111 million to buy out up to three free agent years and his full arbitration cycle. The Atlanta Braves have done this time and again, drawing ire for the minuscule figures owed to Ozzie Albies while still getting silent claps from the baseball community. Ronald Acuña Jr., 2023's likely NL MVP, is under contract through 2026 at a pittance, with team options in place for 2027 and 2028. $100 million used to be the number (that's where Acuña's deal landed). Now, the sum is likely higher for prospect hotshots, but it's still an affordable number for big-budget teams like the Yankees to risk, considering nobody wants to pay $360 million down the line for Aaron Judge if they don't have to.
Only issue, as far as the Yankees are concerned? They haven't, uh, developed anyone else lately. They chose not to go down this path for Gleyber Torres, which has been proven shrewd; the hard-hitting second baseman is inconsistent and might not be a cornerstone of this team's future. For whatever reason, they broke their own mold for Luis Severino and Aaron Hicks. Both deals were cheap, but they were also both disasters. Judge? Cano? One left, one stayed, but both swelled in cost in defiance of the Yankees' stubbornness in earlier years.
The Yankees still won't have any no-brainer extension decisions to make when 2023 wraps, but they've at least begun to enter the arena, thanks to the start of a new class of young players finding their way to the show. This used to be how small-market teams beat the system; think the Rays extending HE WHO MUST NOT BE NAMED in November 2021. Now? It is the system, and the Yankees might have to mess around next winter, if not this one.
JUST MISSED: Clarke Schmidt, who plowed past his career high in innings in 2023 (Previous High: 90.2 back in 2019) and pitched solidly, if unspectacularly, after a difficult start. After finding his footing during an elite summer stretch, he posted seven consecutive outings of 5.20-ERA baseball as fatigue likely set in. Schmidt seems like a very likeable starter/bulldog and potentially a solid No. 4. He also seems like someone the Yankees are more likely to sell high on than commit to.
Assessing 3 possible way-too-early Yankees extensions: Yes or No?
Anthony Volpe, SS
Considering Anthony Volpe's emergence is the singular reason the Yankees decided not to entertain the high costs of free agent shortstops like Corey Seager, Carlos Correa, Trevor Story and Marcus Semien, it's only natural that he should be the most prominent name atop their list of long-term priorities.
Of course, given that their reliance on Volpe to fill a shortstop hole was due, in large part, to the 22-year-old being on a rookie contract, the Yankees probably won't be terribly enthusiastic about paying him a lump sum after Year 1 -- especially a Year 1 that many viewed as slightly disappointing.
It's not tough to play around with Volpe's numbers and find a high-quality player; 20 homers and 20 stolen bags (a rarity for any Yankee, let alone a rookie) speaks for itself. But, at the end of the day, Volpe is a developmental project, not a finished product. This is a ~.210 hitter who woke up from a slumber in the summer, made tangible progress, but didn't sustain it into a piping hot finish.
He's certainly looked like a long-term solution for the Yankees at times this season, and the tools (and intangibles) are there. But the Yankees probably won't want to move too fast here. If he takes a second-year leap forward, they should lock in an extra two prime years next winter when things are only slightly more expensive.
VERDICT: Maybe in 2024.
Michael King, RHP
Michael King has earned a spot here by wedging himself halfway between a relief role and a starting job in 2023. Who decided to make King a starter midstream, one year after suffering a serious elbow issue that derailed the Yankees' 2022 postseason hopes? Did King push for it until he got his way? Did the Yankees believe they'd be getting more value out of King's arm if he could cover five innings rather than two at the back end?
If it's the latter, then the Yankees probably wouldn't be too keen on paying extra for his services after just a few months of experimenting (King is under team control through 2026).
If it was King who desperately wanted to be a starter again and couldn't wait for 2024, maybe he'd be willing to reward the Yankees for testing it out and fulfilling his dreams by agreeing to a discounted contract? Something that buys out his remaining two arbitration years and tacks on two more for, say, $25 million?
King probably knows better, and is eyeing a free agent payday in 2025-2026 after what he hopes will be two successful seasons in the rotation. He's been worth 2.7 bWAR in 2023 despite some midyear relief dips, and has allowed just three earned runs in 28.1 innings since leaving the bullpen behind on Aug. 20.
Side note, why did the Yankees start him a few times, then use him in high-leverage relief against Boston (it didn't go well) before sending him back into the rotation? Why do they do anything that they do?
King is an interesting candidate here (who's becoming more interesting with every start), but he'd probably want a full "prove it" year in the rotation before considering any Yankees overtures.
VERDICT: King says no if asked.
Jasson Dominguez, OF
If Dominguez had finished the month of September healthy, I think the Yankees legitimately could've considered this, and the slugger's camp might've been attentive.
As it stands, extending him at the figure the team would be comfortable with during Dominguez's upcoming lengthy Tommy John rehab would likely make zero sense for the player, rendering this conversation a non-starter.
Ironically, the agent who facilitated Carroll's early extension also represents Dominguez, and if the Yankees wanted to flex their financial muscles by offering a fully healthy 20-year-old Martian a ~$120 million deal through 2032, he would've had the perfect representation for getting it to the finish line.
Sadly, while his lengthy rehab process is unlikely to affect his long-term future, it just doesn't feel like Yankees-style business to plop $100+ million in guarantees in front of a player with a UCL tear (as well as, let's face it, a player who was sliding down prospect rankings before his boffo debut).
Dominguez will have plenty more runway to prove himself essential moving forward once he returns midway through 2023, and if he looks similarly excellent, the Yankees have to, have to, have to make a contract proposal during the following offseason. It shouldn't cost them much more than it would now, and any additional cost is simply the cost of doing business in MLB in 2023 and beyond.
VERDICT: 1,000% Yes ... after 2024.